Adult bovine serum (ABS) provides many nutrients and growth
factors required for cell survival and growth in culture medium. It is one of
the most commonly used blood-derived products for cell culture applications in
biotechnology and pharmaceutical industries. ABS supports the growth of various
cell types and maintains cells viability and morphology. The nutrients,
vitamins, and proteins present in serum help in cell adhesion, proliferation,
and differentiation. ABS is derived from bovine blood collected from adult
cattle.
The Global
Adult Bovine Serum Market is estimated to be valued at US$ 145.13 Bn in 2024
and is expected to exhibit a CAGR of 10 % over the forecast period 2024 to
2031.
Key Takeaways
Key players operating in the Adult Bovine Serum are Flex, TE Connectivity,
Sanmina, Jabil, Celestica, Plexus, and Tecomet, among others. These players are
focusing on new product launches, partnerships, and strategic collaborations to
expand their market share. For instance, in 2021, Thermo Fisher Scientific
launched a new line of ABS designed to improve cell culture performance and
reproducibility.
The growing
Adult
Bovine Serum Market Demand for ABS from biopharmaceutical companies and
research organizations is a major factor driving the market. ABS is widely used
in vaccine production, stem cell research, therapeutic antibody development,
and cancer research. Additionally, rising R&D spending on cell-based
research for developing novel biologics and therapeutics is also propelling the
demand.
Globally, North America dominates the adult bovine serum market due to
increased funding for cell-based research by governments and private
organizations. However, Asia Pacific is expected to witness the highest growth
over the forecast period. This is attributed to rising investments by
international players to establish manufacturing and R&D facilities in
countries such as China and India.
Market Key Trends
Serum-free medium replacing animal-derived products is one of the key trends
witnessed in the adult bovine serum market. Increasing concerns over undefined
components, batch-to-batch variability, and potential risks of contamination
from ABS have prompted end-users to switch to alternative animal-free and
serum-free media. Players are developing novel formulations to address these
issues and make cell culture procedures more defined and reproducible. They are
utilizing plant-derived components, defined recombinant proteins, and synthetic
peptides for developing innovative serum-free media. This is expected to
restrict the market growth of ABS over the forecast period.
Porter's
Analysis
Threat of new entrants: The threat is low due to the high capital requirement and
the need for technical expertise.
Bargaining power of buyers: The bargaining power of buyers
is low as the market has many suppliers and the switching cost for buyers is
low.
Bargaining power of suppliers: The suppliers have moderate
power due to concentration in few regions.
Threat of new substitutes: The threat of substitutes is low
as there are limited substitutes for Adult Bovine Serum.
Competitive rivalry: The rivalry is high due to many players
operating in the market.
Geographical Regions
North America currently holds the largest share of the global Adult Bovine
Serum market in terms of value owing to technological advancements and growing
biopharmaceutical industry in the region. Asia Pacific is expected to be the
fastest growing region during the forecast period due to increasing government
funding in healthcare and biomedical research. Countries like China and India
are expected to offer lucrative opportunities for market players.
Get More
Insights on- Adult
Bovine Serum Market
About
Author:
Money
Singh is a seasoned
content writer with over four years of experience in the market research
sector. Her expertise spans various industries, including food and beverages,
biotechnology, chemical and materials, defense and aerospace, consumer goods,
etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment